Literature DB >> 19161929

An elderly patient with fluoroquinolone-associated achilles tendinitis.

Emily Damuth1, Joel Heidelbaugh, Preeti N Malani, Sandro K Cinti.   

Abstract

BACKGROUND: Due to their broad-spectrum activity and oral bioavailability, fluoroquinolone antibiotics are commonly prescribed to adults aged >60 years for many common community-acquired infections. The association between fluoroquinolone use and Achilles tendinitis is well established but sometimes missed in clinical practice. Older patients and patients with renal dysfunction are at particularly increased risk for this complication. CASE
SUMMARY: We present a case of Achilles tendinitis in a 77-year-old patient with renal dysfunction and a urinary tract infection (UTI) treated with ciprofloxacin 250 mg PO QD. Tendinitis developed within several days of the start of treatment and improved within 2 days of treatment cessation, without the need for intervention. The likelihood of ciprofloxacin having caused this reaction was probable (Naranjo score, 7). Early diagnosis and treatment cessation might have prevented tendon rupture, and the tendinitis resolved completely with subsequent physical therapy.
CONCLUSION: Based on this outcome in this patient with UTI, fluoroquinolones should be used with caution, particularly in patients with risk factors predisposing to tendinitis, including advanced age and renal dysfunction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19161929     DOI: 10.1016/j.amjopharm.2008.11.002

Source DB:  PubMed          Journal:  Am J Geriatr Pharmacother        ISSN: 1876-7761


  5 in total

1.  The Risk of Fluoroquinolone-induced Tendinopathy and Tendon Rupture: What Does The Clinician Need To Know?

Authors:  Grace K Kim
Journal:  J Clin Aesthet Dermatol       Date:  2010-04

Review 2.  Fluoroquinolones and tendinopathy: a guide for athletes and sports clinicians and a systematic review of the literature.

Authors:  Trevor Lewis; Jill Cook
Journal:  J Athl Train       Date:  2014-04-24       Impact factor: 2.860

3.  Fluoroquinolone-induced serious, persistent, multisymptom adverse effects.

Authors:  Beatrice Alexandra Golomb; Hayley Jean Koslik; Alan J Redd
Journal:  BMJ Case Rep       Date:  2015-10-05

Review 4.  Safety considerations of fluoroquinolones in the elderly: an update.

Authors:  Ralf Stahlmann; Hartmut Lode
Journal:  Drugs Aging       Date:  2010-03-01       Impact factor: 3.923

5.  Work related etiology of de Quervain's tenosynovitis: a case-control study with prospectively collected data.

Authors:  Stéphane Stahl; Daniel Vida; Christoph Meisner; Adelana Santos Stahl; Hans-Eberhard Schaller; Manuel Held
Journal:  BMC Musculoskelet Disord       Date:  2015-05-28       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.